What is HSCS's market cap?

$15.02M, based on the Nov 4 close of $3.10.

Does HeartSciences pay a dividend?

No regular cash dividend has been paid in the last year.

How much of HSCS is sold short?

63.1K shares, 1.9% of float, as of Oct 15, 2026.

What sector is HSCS in?

Financials, in the Banking & Credit industry.

NASDAQ · HSCSFinancialsBanking & Credit

HeartSciences Inc. Common Stock (HSCS)

$3.10+5.08%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$3.10▲ 9.54% in range

Nov 4, 2025Low $1.67 · High $5.20Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

HeartSciences closed at $3.10 on Nov 4, up 5.08%, 40.4% below its 52-week closing high. Volume of 100.7K shares was 1.12× its 20-day average (close to normal).

Split-adjusted performance: -17.8% over one month, +71.3% over six months, +5.8% over one year.

In the quarter ended Jul 31, 2026, revenue was $2.10K, up 10.5% from a year earlier, with a net margin of -151064.0%.

Short interest was 63.1K shares at the Oct 15 settlement, up 126.1% from the prior report (1.9% of float, 1.0 days to cover).

Market cap$15.0M4.8M shares

Revenue · quarter$2.1K+10.5% YoY

Diluted EPS$-0.86—

P/E · TTM—P/S 3,322.9×

Net margin-151,064.0%Gross 63.8%

Dividend yieldNone

52-week range1.67 – 5.20−40.4% from high

Volume100.7K1.12× 20-day avg

Volatility · 60d122.2%Annualised

Short % of float1.9%1.0 days to cover

Net cash-$4.0MCash $29.9K

Next earnings—Not scheduled

Split-adjusted performance

1W −8.0%1M −17.8%3M +55.0%6M +71.3%YTD +0.3%1Y +5.8%3Y −87.3%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Banking & Credit

Percentile among 435 companies (100 = best)

6-month momentum99

Revenue growth65

Net margin0

Value (low P/E)—

Size2

Industry medians: 6-month return +7.4%, revenue growth +5.2%, net margin 18.2%, P/E 12.5×.

Short interest

Details →

Shares short63.1K+126.1% vs prior

Days to cover1.0Settled Oct 15

% of float1.9%

Short vol. 10d50.0%of daily volume

Closest peers by size in Banking & Credit

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
HSCSHeartSciences	$3.10	+5.08%	+71.3%	+10.5%	−151064.0%	—	$15.0M
BGDEBig Digital Energy	$2.77	−12.06%	—	—	−119.9%	—	$15.7M	Compare
MDBHMDB Capital Holdings, LLC	$1.55	+8.39%	−60.2%	+337.5%	−378.6%	—	$16.2M	Compare
DRKDarkHorse Technologies	$1.72	−7.28%	—	—	—	—	$18.2M	Compare
BENFBeneficient	$0.7750	−1.70%	−77.5%	−75.5%	−1887.0%	—	$12.0M	Compare
BCGBinah Capital Group	$1.16	+9.43%	−45.5%	+11.8%	−0.1%	8.9	$19.8M	Compare
NCPLNetcapital	$1.41	−9.62%	+255.2%	−38.2%	−1921.5%	—	$11.3M	Compare
VIPVulcan Infrastructure and Power	$1.13	−4.24%	—	—	—	—	$20.8M	Compare
ATCHAtlasClear Holdings	$0.1403	+1.74%	−44.7%	+136.8%	−37.4%	10.9	$21.3M	Compare

News about HeartSciences

All news →

HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research · Sep 14, 2026▼ Negative

Quick answers

What does HeartSciences do?: HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
What is HSCS's market cap?: $15.02M, based on the Nov 4 close of $3.10.
Does HeartSciences pay a dividend?: No regular cash dividend has been paid in the last year.
How much of HSCS is sold short?: 63.1K shares, 1.9% of float, as of Oct 15, 2026.
What sector is HSCS in?: Financials, in the Banking & Credit industry.

About HeartSciences

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.

HQ: Southlake, TX14 employeesListed Jun 15, 2022heartsciences.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology